MARKET

ONVO

ONVO

Organovo Holding
NASDAQ
1.590
0.000
0.00%
After Hours: 1.571 -0.019 -1.18% 16:19 01/27 EST
OPEN
1.560
PREV CLOSE
1.590
HIGH
1.630
LOW
1.550
VOLUME
21.80K
TURNOVER
0
52 WEEK HIGH
4.670
52 WEEK LOW
1.370
MARKET CAP
13.85M
P/E (TTM)
-1.1591
1D
5D
1M
3M
1Y
5Y
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga · 12/21/2022 13:07
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga · 11/24/2022 13:06
Organovo Announces Target Validation Ahead Of Schedule, Accelerating Timeline For First Crohn's Disease Drug Candidates
Benzinga · 11/15/2022 13:17
Why Spero Therapeutics Is Trading Higher By Over 105%; Here Are 21 Stocks Moving Premarket
Gainers Spero Therapeutics, Inc. (NASDAQ: SPRO) rose 105.6% to $1.69 in pre-market trading. GSK and Spero Therapeutics announced exclusive license agreement for late-stage antibiotic asset, Tebipenem HBr.
Benzinga · 09/22/2022 10:34
Why Applied Optoelectronics Is Trading Higher By Around 31%; Here Are 21 Stocks Moving Premarket
Gainers Kensington Capital Acquisition Corp. IV (NYSE: AMPX) rose 159.4% to $25.94 in pre-market trading after gaining 11% on Thursday.
Benzinga · 09/16/2022 10:35
UiPath, Frontline, FLEX LNG among premarket losers' pack
Shuttle Pharmaceuticals Holdings (SHPH) -22%. UiPa...
Seekingalpha · 09/07/2022 12:29
Why Allena Pharmaceuticals Tumbled Over 30%; Here Are 85 Biggest Movers From Yesterday
Gainers Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ: SHPH) shares jumped 91.3% to close at $28.50 on Tuesday amid post-IPO volatility.
Benzinga · 09/07/2022 09:16
Why HyreCar Is Trading Higher By 60%, Here Are 63 Stocks Moving In Tuesday's Mid-Day Session
Gainers HyreCar Inc. (NASDAQ: HYRE) jumped 60% to $1.2680 after the company announced it has received a $100 million revolving line of credit from a premier global investment bank and Medalist Partners.
Benzinga · 09/06/2022 17:36
More
About ONVO
Organovo Holdings, Inc. is an early stage biotechnology company that focuses on building high fidelity, three-dimensional (3D) tissues that recapitulate various aspects of human disease. The Company uses these models to identify gene targets responsible for driving the disease and intends to initiate drug discovery programs around these validated targets. It is initially focusing on the intestine and has ongoing 3D tissue development efforts in ulcerative colitis (UC) and Crohns disease (CD). It uses its technology to build functional 3D human tissues that mimic various aspects of native human tissue composition, architecture, function, and disease. Its NovoGen Bioprinters are automated devices that enable the fabrication of 3D living tissues comprised of mammalian cells. Its NovoGen Bioprinters can also dispense pure hydrogel formulations, provided the physical properties of the hydrogel are compatible with the dispensing parameters. Its 3D human tissue platform is multifaceted.

Webull offers kinds of Organovo Holdings Inc stock information, including NASDAQ:ONVO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ONVO stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading ONVO stock methods without spending real money on the virtual paper trading platform.